How can nanorobots be achieved?
In the same way microelectronics has provided new medical devices in the 80s, now the miniaturization through nanotechnology is enabling the manufacturing of nanobiosensors and actuators to improve cell biology interfaces and biomolecular manipulation. Fully operational nanorobots for biomedical instrumentation should be achieved as a result of nanobioelectronics and proteomics integration.

Tell us about your work and how simulation can help in machine prototyping?

What types of biomedical applications do you propose for this hardware architecture?

What path are you taking to implement nanorobots?
The next steps in our work can be defined as follows: (a) model manufacturing with CNT-CMOS biochip integration; (b) laboratory studies for in vivo tests; and (c) commercialization. The pipeline for development in the medical sector typically requires research and efforts to get new ideas out of laboratories and into the marketplace. For a therapeutic new drug, surgical devices or even a simple new vaccine: time, resources and creativity are demanded to make it happen. The rules are always the same and it would not be any different for medical nanorobots. We are aware of it, and we are working cooperatively to lead such a development.